Source: Market Cheetah

Akeso Biomedical: Akeso Biomedical Files TYPLEX Chelate Dossier to Reduce Campylobacter in EU Poultry

WALTHAM, Mass.-(BUSINESS WIRE)-#Campylobacter-Akeso Biomedical files TYPLEX Chelate Dossier to reduce Campylobacter in EU poultry. Commercial trials also demonstrate increased weight gain and feed conversion when TYPLEX added to broiler feeds. Source: BusinessWire-Primary Akeso Biomedical ...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Simon F Williams's photo - CEO of Akeso Biomedical

CEO

Simon F Williams

CEO Approval Rating

68/100

Read more